Interpace Biosciences Inc SMA 200
Was ist das SMA 200 von Interpace Biosciences Inc?
SMA 200 von Interpace Biosciences Inc ist $1 +6.92%
Was ist die Definition von SMA 200?
SMA 200 ist ein durchschnittlicher Aktienkurs der letzten 200 Tage, berechnet als ungewichteter Mittelwert der letzten 200 Schlusskurse.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Interpace Biosciences Inc
Was macht Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Unternehmen mit sma 200 ähnlich Interpace Biosciences Inc
- Theratechnologies hat SMA 200 von $1 -10.80%
- APM Human Services International hat SMA 200 von AUD$1 +5.28%
- Jiashili hat SMA 200 von HKD$1 -27.57%
- Titanium hat SMA 200 von CAD$1 +28.16%
- Core One Labs hat SMA 200 von $1 +68.62%
- MicroVision hat SMA 200 von $1 -37.99%
- Interpace Biosciences Inc hat SMA 200 von $1 +6.92%
- DarioHealth Corp hat SMA 200 von $1 -73.25%
- Pipestone hat SMA 200 von CAD$1 -92.96%
- Diaceutics Plc hat SMA 200 von $1 -0.20%
- Energous Corp hat SMA 200 von $1 -75.89%
- Lion Rock hat SMA 200 von HKD$1 -0.92%
- Fiore Gold hat SMA 200 von CAD$1 +1.90%